Human Resources
We are not actively recruiting at present.
Products
VIRTTU's lead product SEPREHVIR®, a "First in Class" oncolytic virus, shows broad utility against a range of difficult to treat cancers.
Advice and Support for Patients
If you are suffering from any form of cancer or know anyone that is, click here for links to organisations that offer advice and support.